Testosterone Treatment and Fractures in Men with Hypogonadism


Abstract

Background

Testosterone treatment in men with hypogonadism improves bone density and quality, but trials with a sufficiently large sample and a sufficiently long duration to determine the effect of testosterone on the incidence of fractures are needed.

Methods

In a subtrial of a double-blind, randomized, placebo-controlled trial that assessed the cardiovascular safety of testosterone treatment in middle-aged and older men with hypogonadism, we examined the risk of clinical fracture in a time-to-event analysis. Eligible men were 45 to 80 years of age with preexisting, or high risk of, cardiovascular disease; one or more symptoms of hypogonadism; and two morning testosterone concentrations of less than 300 ng per deciliter (10.4 nmol per liter), in fasting plasma samples obtained at least 48 hours apart. Participants were randomly assigned to apply a testosterone or placebo gel daily. At every visit, participants were asked if they had had a fracture since the previous visit. If they had, medical records were obtained and adjudicated.

Results

The full-analysis population included 5204 participants (2601 in the testosterone group and 2603 in the placebo group). After a median follow-up of 3.19 years, a clinical fracture had occurred in 91 participants (3.50%) in the testosterone group and 64 participants (2.46%) in the placebo group (hazard ratio, 1.43; 95% confidence interval, 1.04 to 1.97). The fracture incidence also appeared to be higher in the testosterone group for all other fracture end points.

Conclusions

Among middle-aged and older men with hypogonadism, testosterone treatment did not result in a lower incidence of clinical fracture than placebo. The fracture incidence was numerically higher among men who received testosterone than among those who received placebo

Testosterone Tx Improves Anemia in Male Hypogonadism


Testosterone replacement therapy (TRT) is more effective than placebo in both correcting anemia and preventing anemia in middle-aged and older men with hypogonadism, according to a new analysis published online in JAMA Network Open.

The analysis comes from a randomized, placebo-controlled trial that included 5,204 men with hypogonadism at 316 U.S. sites. This study was nested within the Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy Response in Hypogonadal Men (TRAVERSE) Study. That study looked at whether TRT had an effect on major cardiovascular events and results were published earlier this year in the New England Journal of Medicine.

Hypogonadism increases with age

Hypogonadism includes specific symptoms in addition to a low testosterone level and has a lower prevalence (about 6%-12% vs. about 25% with low testosterone alone) in men 40-70 years old in the Massachusetts Male Aging Study (MMAS). But it is still common and increases with age, note authors of the current study, led by Karol M. Pencina, PhD, with the Research Program in Men’s Health: Aging and Metabolism, at Brigham and Women’s Hospital and Harvard Medical School, Boston.

Symptoms of hypogonadism include lower libido, erectile dysfunction, fatigue, reduced muscle mass, poor concentration, and disturbed sleep.

No approved treatment

Currently, there is no approved treatment for unexplained anemia during aging and nearly 15% of older men with hypogonadism experience anemia, the authors explain.

The proportion of participants whose anemia was corrected was significantly higher in the TRT group than the placebo group at 6 months (143 of 349 [41.0%] vs. 122 of 360 [27.5%]), 12 months (45.0% vs. 33.9%), 24 months (42.8% vs. 30.9%), 36 months (43.5% vs. 33.2%), and 48 months (44.6% vs. 39.2%); omnibus test P = .002.

A second aim in the study was to determine the effect of TRT on the development of anemia in participants who did not have anemia at enrollment.

In that group, a significantly smaller proportion of participants in the treatment group developed anemia, compared with the placebo group at 6 months (143 of 1,997 [7.2%] vs. 203 of 1,958 [10.4%]), 12 months (7.1% vs. 9.0%), 24 months (10.0% vs. 12.3%), 36 months (10.0% vs. 12.9%), and 48 months (9.0% vs 10.2%); omnibus test P  = .02.

The men in the study had an average age of 64.8; 66.7% were White; 30.3% were Black; 2% were other.

Clinical implications

Shabbir M. H. Alibhai, MD, MSc, with the Institute of Health Policy, Management, and Evaluation, Institute of Medical Sciences, department of medicine, University of Toronto, writes in an invited commentary that this is one of the largest trials of TRT and was well-designed and executed. He points out that it had a long follow-up (mean duration on TRT was more than 20 months).

Given the results, he says, “TRT appears to be generally safe in middle-aged and older men with symptomatic hypogonadism, corrected mild anemia in 10%-15% of recipients, and prevented anemia in 2%-3%, with small improvements in energy but no effect on self-reported cognitive function.”

He said that without further details on long-term benefit, “I would not offer TRT primarily to treat asymptomatic normocytic anemia in men with low testosterone levels. It is reasonable to offer TRT to men with symptomatic hypogonadism regardless of hemoglobin level.”

He advises counseling patients that they could see small increases in hemoglobin levels with TRT, with a small boost in energy if they had anemia, but the effect on cognition, well-being, or function is unclear.

He further advised, “Hemoglobin levels should be monitored in men starting TRT (to detect the development of polycythemia), and prostate-specific antigen levels should be normal prior to start of treatment. Of course, a basic workup for causes of anemia, guided by history and basic parameters such as the mean corpuscular volume and blood film, should be performed in all men with anemia regardless of levels.”

Testosterone Treatment and Fractures in Men with Hypogonadism


Abstract

Background

Testosterone treatment in men with hypogonadism improves bone density and quality, but trials with a sufficiently large sample and a sufficiently long duration to determine the effect of testosterone on the incidence of fractures are needed.

Methods

In a subtrial of a double-blind, randomized, placebo-controlled trial that assessed the cardiovascular safety of testosterone treatment in middle-aged and older men with hypogonadism, we examined the risk of clinical fracture in a time-to-event analysis. Eligible men were 45 to 80 years of age with preexisting, or high risk of, cardiovascular disease; one or more symptoms of hypogonadism; and two morning testosterone concentrations of less than 300 ng per deciliter (10.4 nmol per liter), in fasting plasma samples obtained at least 48 hours apart. Participants were randomly assigned to apply a testosterone or placebo gel daily. At every visit, participants were asked if they had had a fracture since the previous visit. If they had, medical records were obtained and adjudicated.

Results

The full-analysis population included 5204 participants (2601 in the testosterone group and 2603 in the placebo group). After a median follow-up of 3.19 years, a clinical fracture had occurred in 91 participants (3.50%) in the testosterone group and 64 participants (2.46%) in the placebo group (hazard ratio, 1.43; 95% confidence interval, 1.04 to 1.97). The fracture incidence also appeared to be higher in the testosterone group for all other fracture end points.

Conclusions

Among middle-aged and older men with hypogonadism, testosterone treatment did not result in a lower incidence of clinical fracture than placebo. The fracture incidence was numerically higher among men who received testosterone than among those who received placebo.

Hypogonadism increases likelihood of hospitalization for men with COVID-19


Men with hypogonadism who contract COVID-19 are more likely to be hospitalized compared with those with normal testosterone levels, according to study findings published in JAMA Network Open.

Sandeep Dhindsa

“Historically, the screening for hypogonadism and treatment of testosterone is dependent upon the presence of symptoms such as decreased sexual desire and low energy,” Sandeep Dhindsa, MD, professor of medicine and chief of the division of endocrinology and metabolism at Saint Louis University, told Healio. “However, studies over the last decade have demonstrated that low testosterone adversely impacts metabolic health (such as increased risk of diabetes), and testosterone treatment decreases that risk. Our study brings forth another impact of low testosterone: decreased ability to overcome an illness such as COVID-19.”

Hypogonadism linked to COVID-19 hospitalization in men
Men with hypogonadism were more likely to be hospitalized or admitted to the ICU after being infected with COVID-19 compared with men with eugonadism. Data were derived from Dhindsa S, et al. JAMA Netw Open. 2022;doi:10.1001/jamanetworkopen.2022.29747.

Dhindsa and colleagues conducted a retrospective cohort study of 723 adult men who had a history of COVID-19 infection and at least one testosterone concentration measurement from 2017 to 2021 (mean age, 55 years). Data were obtained from the electronic health records of two major health systems in St. Louis. Demographics, comorbidities, COVID-19 hospitalization and data on receipt of testosterone therapy were collected. Men were included in a testosterone therapy group if they had received testosterone for at least 6 months before their COVID-19 infection. For men hospitalized with COVID-19, duration of stay, ICU admission, ventilator use and mortality were collected. The lower limit of a normal testosterone level was 175 ng/dL to 300 ng/dL. Men were defined as having hypogonadism if their total testosterone was below the lower limit of normal.

Of the study cohort, 116 had hypogonadism, 427 had a normal testosterone level and 180 were receiving testosterone therapy. There were 134 participants hospitalized with COVID-19. Men in the hypogonadism group were more likely to be hospitalized with COVID-19 (45% vs. 12%) and be admitted to the ICU (9% vs. 3%) than those with normal testosterone levels. The risk for ventilator use and mortality was similar between those with hypogonadism and those with eugonadism.

After adjusting for confounders, men with hypogonadism were more likely to be hospitalized with COVID-19 (adjusted OR = 2.4; 95% CI, 1.4-4.4; P < .003) compared with those with eugonadism. There was no difference between the two groups in ICU admission. No difference in hospitalization was found between the testosterone therapy and eugonadism groups. Older men (aOR = 1.03; 95% CI, 1.01-1.05; P = .02) and those who were immunosuppressed (aOR = 3.5; 95% CI, 1.5-7.8; P = .003) were also more likely to be hospitalized with COVID-19.

Hospitalization rates in the cohort increased with a testosterone concentration of less than 200 ng/dL. Of 32 men receiving androgen deprivation therapy for prostate cancer, 56% were hospitalized due to COVID-19 and 9% were admitted to the ICU.

Median testosterone concentrations in men receiving testosterone therapy were similar to men with eugonadism. Of the testosterone therapy group, 24% had subnormal testosterone concentrations. The odds for COVID-19 hospitalization were increased for men with subnormal testosterone levels receiving therapy compared with those with normal concentration while on testosterone therapy (aOR = 3.5; 95% CI, 1.5-8.6; P = .003).

“We were surprised to find that low testosterone actually increased the risk of hospitalization,” Dhindsa said. “This risk was independent of other known risk factors. The fact that testosterone treatment lowered the risk further solidified our finding that low testosterone should be considered a risk factor for hospitalization from COVID-19.”

Dhindsa said it is too early to recommend testosterone therapy as a method for preventing hospitalization from COVID-19 and other acute illnesses, but studies should investigate whether testosterone can have a beneficial effect.

Low Testosterone and Heart Disease Linked—But What’s Really Causing Them?


Story at-a-glance

  • After age 30, a man’s testosterone levels begin to decline, and continue to do so as he ages, leading to symptoms such as decreased sex drive, erectile dysfunction, depressed mood, and difficulties with concentration and memory
  • According to a recent analysis, low testosterone may increase a man’s risk for cardiovascular disease. The mechanism of harm in still unknown, and both low testosterone and heart disease may simply be the result of poor overall health
  • Estrogen, the female sex hormone, plays a much bigger role in men’s heath than previously thought. Both hormones have been found to be important for sexual function, and a deficiency in either has a negative impact on a man’s libido
  • While testosterone deficiency accounts for decreases in lean mass, muscle size and strength, estrogen deficiency in men is the primary culprit when it comes to increases in body fat
  • Dietary and exercise changes, particularly limiting sugar/fructose, eating healthy saturated fats and engaging in high-intensity exercises, Power Plate, and strength training, can be very effective at boosting testosterone levels naturally.
  • Heart Problems

Testosterone is an androgenic sex hormone produced by a man’s testicles, and to a lesser degree, in smaller amounts, by the ovaries in women. While testosterone is stereotypically associated with virility, it also plays a role in maintaining muscle mass, bone density, red blood cells, and a general sense of well-being. 

Beginning around age 30, a man’s testosterone levels begin to decline, and continue to do so as time goes on—unless you proactively address your lifestyle.

Chemical exposures, including prescription drugs like statins, can also have an adverse effect on your testosterone production. Symptoms of decliningtestosterone levels include:

  • Decreased sex drive
  • Erectile dysfunction and/or problems urinating
  • Depression
  • Difficulties with concentration and memory
  • Weight gain and/or breast enlargement

According to a recent analysis,1 low testosterone may also increase a man’s risk for cardiovascular disease. As reported in the featured article:2

“To arrive at their findings, the research team examined previous studies that analyzed cardiovascular disease and testosterone levels between 1970 and 2013. The review of the studies revealed modest evidence that low testosterone levels are linked to an increased risk of cardiovascular disease.

However, the researchers note there was little evidence of a link between low testosterone and artherosclerosis – the hardening and narrowing of the arteries that can lead to heart attacks and strokes, and there was no evidence of a specific link between heart attacks and testosterone levels.”

The Importance of Testosterone for General Health

While the exact mechanism linking low testosterone to heart disease could not be ascertained, the researchers suggest the effect might be related to thrombosis or arrhythmia. Thrombosis is when a blood clot develops, and arrhythmia is basically a condition in which your heart beats erratically. Previous research has linked low testosterone with both of these conditions, plus a number of others, including:

  • Increased blood pressure
  • Dyslipidemia
  • Endothelial dysfunction
  • Impaired left ventricular function

Interestingly enough however, they also found that testosterone replacement therapy did NOT have any positive effect on cardiovascular health. This could potentially indicate that low testosterone does not in and of itself promote heart disease, but rather that low T and heart disease are both caused by something else. As stated by lead researcher, Dr. Johannes Ruige:3

“Based on current findings, we cannot rule out that low testosterone and heart disease both result from poor overall health.”

Indeed, I know first-hand that low testosterone is not an automatic outcome of aging, provided you incorporate certain lifestyle strategies that can naturally boost your testosterone levels, which I’ll review below. These strategies are part and parcel of an overall healthy lifestyle, so they also automatically reduce your risk of most chronic disease, including heart disease.

It actually makes logical sense that failure to incorporate these foundational health-promoting strategies could be the root cause of low testosterone, heart disease, and all the heart-related adverse effects listed above.

The Role of Estrogen in the Aging Male

Both men and women make estrogen out of testosterone. As a result, some men can actually end up with close to twice the amount of estrogen found in postmenopausal women. Still, the levels of both testosterone and estrogen both tend to decline with age, and as they do, your body changes. So far, researchers have almost exclusively focused on estrogen’s effect on women, and testosterone’s impact on men. But that may soon change.

A recent article in the New York Times4 highlighted research demonstrating the intricate play of women’s sex hormones in aging men’s health—a factor that has so far been largely ignored:

“Estrogen, the female sex hormone, turns out to play a much bigger role in men’s bodies than previously thought, and falling levels contribute to their expanding waistlines just as they do in women’s. The discovery of the role of estrogen in men is ‘a major advance,’ said Dr. Peter J. Snyder, a professor of medicine at the University of Pennsylvania, who is leading a big new research project on hormone therapy for men 65 and over. Until recently, testosterone deficiency was considered nearly the sole reason that men undergo the familiar physical complaints of midlife. “

The study in question, published in the New England Journal of Medicine5 (NEJM), found that there were significant individual variations in the amount of testosterone required for any particular man to maintain lean body mass, strength, and sexual function.

However, they were able to determine that testosterone deficiency accounted for decreases in lean mass, muscle size and strength, while estrogen deficiency was the primary culprit when it came to increases in body fat. Both hormones were found to be important for sexual function, and a deficiency in either had a negative impact on the men’s libido. According to the lead author, Dr. Joel Finkelstein, an endocrinologist at Harvard Medical School:

“Some of the symptoms routinely attributed to testosterone deficiency are actually partially or almost exclusively caused by the decline in estrogens.”

Despite individual variations, Dr. Finkelstein’s research offers valuable insight into the function and behavior of estrogen and testosterone at different levels in a man’s body. For example, they found that less testosterone is actually needed for muscle maintenance than previously thought. They also found that:

  • In young men, the average testosterone level is about 550 nanograms per deciliter (ng/dl)
  • Muscle size and strength does not become adversely affected until testosterone levels drop below 200 ng/dl, which has previously been considered extremely low
  • Fat accumulation, however, increases at testosterone levels of 300-350 ng/dl, due to its impact on estrogen
  • Libido increases steadily with simultaneous increases in testosterone and estrogen

Please note that men are NOT advised to take estrogen replacement therapy, as this could cause feminization, such as enlarged breasts. As your testosterone levels rise, your body will automatically produce more estrogen, so the key is to maintain your testosterone level—ideally by incorporating the strategies I will discuss below.

How to Raise Your Testosterone Levels Naturally Through Exercise

Personally, I do not recommend using testosterone hormone replacement. If you indeed have low testosterone, you can consider trans rectal DHEA cream, which I’ll discuss below. DHEA is the most abundant androgen precursor prohormone in the human body, meaning it’s the largest raw material your body uses to produce other vital hormones, including testosterone in men and estrogen in women. However, I believe many of you may not even need that, were you to take full advantage of your body’s natural ability to optimize hormones like testosterone and human growth hormone (HGH).

Just like testosterone, your HGH levels also sharply decline after the age of 30, as illustrated in the graph above. Both of these hormones are also boosted in response to short, intense exercise. As I do not take any hormone or prohormone supplements, I’ve been doing Peak exercises for just over three years now, and at the age of 59, my testosterone level (done last month) and HGH levels (listed below) are still well within the normal range for a young adult male without the aid of ANY prescriptions, hormones and hormone precursor supplements:

  • Total testosterone: 982 ng/dl (normal test range: 250-1,100 ng/dl)
  • Free testosterone: 117 pg/ml (normal test range: 35-155 pg/ml)
  • HGH: 14,000 pg, more than three times the normal test range of 1,000-4,000 pg/24 hours

Below is a summary and video demonstration of what a typical high-intensity Peak Fitness routine might look like. As you can see, the entire workout is only 20 minutes, and 75 percent of that time is warming up, recovering or cooling down. You’re really only working out intensely for four minutes. It’s hard to believe if you have never done this, that you can actually get that much benefit from only four minutes of intense exercise, but that’s all you need!

  • Warm up for three minutes
  • Exercise as hard and fast as you can for 30 seconds. You should feel like you couldn’t possibly go on another few seconds
  • Recover at a slow to moderate pace for 90 seconds
  • Repeat the high intensity exercise and recovery 7 more times.

Four Additional Ways to Boost Testosterone and HGH

Besides high intensity exercise, there are several other strategies that will also boost your testosterone levels naturally. These are appropriate for virtually anyone, male or female, as they carry only beneficial “side effects.” For even more tips, please see my previous article, “9 Body Hacks to Naturally Increase Testosterone.”

    • Weight training. When you use strength training to raise your testosterone, you’ll want to increase the weight and lower your number of reps. Focus on doing exercises that work a wider number of muscles, such as squats or dead lifts. You can take your workout to the next level by learning the principles of Super-Slow Weight Training. For more information on how exercise can be used as a natural testosterone booster, read my article “Testosterone Surge After Exercise May Help Remodel the Mind.”
    • Whole body vibration training (WBVT) using a Power Plate. In addition to the Peak Fitness exercises, I do 10 minutes of Power Plate training twice a day and this likely also improved my hormones. WBVT in some ways simulate high intensity exercise by stimulating your white (fast-twitch) muscle fiber. This kick-starts your pituitary gland into making more growth hormone, which helps you build lean body mass and burn fat.
    • Address your diet. This is critical for a number of reasons. First of all, if you’re overweight, shedding the excess pounds may increase your testosterone levels, according to recent research.6 Testosterone levels also decrease after you eat sugar. This is likely because sugar and fructose raises your insulin level, which is another factor leading to low testosterone. Ideally, keep your total fructose consumption below 25 grams per day. If you have insulin resistance and are overweight, have high blood pressure, diabetes or high cholesterol, you’d be well advised to keep it under 15 grams per day.

The most efficient way to shed excess weight and normalize your insulin levels at the same time is to strictly limit the amount of sugar/fructose and grains in your diet, and replacing them with vegetables and healthy fats, such as organic pastured egg yolks, avocado, coconut oil, butter made from raw grass-fed organic milk, and raw nuts.

Saturated fats are in fact essential for building testosterone. Research shows that a diet with less than 40 percent of energy as fat (and that mainly from animal sources, i.e. saturated) lead to a decrease in testosterone levels.7 My personal diet is about 70-80 percent healthy fat, and other experts agree that the ideal diet includes somewhere between 50-70 percent fat. I’ve detailed a step-by-step guide to this type of healthy eating program in my optimizednutrition plan.

  • Intermittent fasting. Another effective strategy for enhancing both testosterone and HGH release is intermittent fasting. It helps boost testosterone by improving the expression of satiety hormones, like insulin, leptin, adiponectin, glucacgon-like peptide-1 (GLP-1), cholecystokinin (CKK), and melanocortins, which are linked to healthy testosterone function, increased libido, and the prevention of age-induced testosterone decline.

Why I Recommend DHEA Over Testosterone Replacement

I personally do not use any hormone or prohormone treatments as I’ve been successful in getting my hormone levels within the healthy young adult range using the protocols described above. However, if you chose to use hormones it is really crucial to use bioidentical versions. There are synthetic and bioidentical hormone products out on the market, but I advise using bioidentical hormones like DHEA if you opt for this route. DHEA is a hormone secreted by your adrenal glands. Again, this substance is one of the most abundant precursor hormones in your body, and it’s crucial for the creation of hormones, including testosterone and other sex hormones.

Production of this prohormone peaks during your late 20s or early 30s. With age, DHEA production begins to decline, right along with your testosterone and HGH levels. Your adrenal glands also manufacture the stress hormone cortisol, which is in direct competition with DHEA for production because they use the same hormonal substrate known as pregnenolone. Chronic stress basically causes excessive cortisol levels, thereby impairing DHEA production, which is why stress is another factor for low testosterone levels.

It’s important to use any DHEA product with the supervision of a professional. Find a qualified health care provider who will monitor your hormone levels and determine if you actually require supplementation.

Also, rather than using an oral hormone supplementation, I recommend trans-mucosal (vagina or rectum) application. Skin application may not be wise, as it makes it difficult to measure the dosage you receive. This may cause you to end up receiving more than what your body requires. Applying a trans-mucosal DHEA cream to your rectum (or if you are a woman, your vagina) will allow the mucous epithelial membranes that line your mucosa to perform effective absorption. These membranes regulate absorption and inhibit the production of unwanted metabolites of DHEA. That said, I do NOT recommend prolonged supplementation of hormones, even bioidentical ones. Doing so can trick your body into halting its own DHEA production and may cause your adrenals to become impaired.

Other Helpful Supplements

Besides DHEA, there are also nutritional supplements that can not only address some of the symptoms commonly associated with low testosterone, but may help boost your testosterone levels as well. These include:

    • Saw palmetto. Besides addressing symptoms of low testosterone, this herb may also help to actually increase testosterone levels by inhibiting up-conversion to dihydrotestosterone.8 Research has also shown it can help reduce your risk of prostate cancer. When choosing a saw palmetto supplement, you should be wary of the brand, as there are those that use an inactive form of the plant. According to industry expert Dr. Rudi Moerck, what you want to look for is an organic supercritical CO2 extract of saw palmetto oil, which is dark green in color. Since saw palmetto is a fat-soluble supplement, taking it with eggs will enhance the absorption of its nutrients.
    • Astaxanthin in combination with saw palmetto. There is also solid research indicating that if you take astaxanthin in combination with saw palmetto, you may experience significant synergistic benefits. A 2009 study published in theJournal of the International Society of Sports Nutrition found that an optimal dose of saw palmetto and astaxanthin decreased both DHT and estrogen while simultaneously increasing testosterone.9
    • Ashwagandha. This ancient Indian herb is known as an adaptogen, which can help boost stamina, endurance, and sexual energy. Research published in 201010 found that men taking the herb Ashwagandha experienced a significant increase in testosterone levels.

Ashwagandha also helps promote overall immune function, and can help increase your resistance to occasional stress.11 It also supports healthful levels of total lipids, cholesterol, and triglycerides already in the normal range. While some adaptogens are stimulants in disguise, this is not the case with Ashwagandha. It can give your morning exercise routine a boost, and when taken prior to bed, it can help you get a good night’s sleep as well. I recommend using only 100% organic Ashwagandha root, free of fillers, additives and excipients, to ensure quality.

Low Testosterone Is Not an Inevitable Fate for Aging Men

I strongly recommend implementing lifestyle strategies that are known to optimize testosterone levels naturally before you do anything else to address the symptoms associated with low testosterone. If you’re still deficient in testosterone after implementing high intensity exercise and strength training, along with the dietary strategies detailed above and, ideally, intermittent fasting, then you could try trans-mucosal DHEA. Again, remember to confer with a qualified health care practitioner and get your levels tested before supplementing with DHEA or any other hormone, including testosterone.

Personally, I’ve been able to maintain both testosterone and HGH levels comparable to that of a young healthy male, simply by implementing high intensity exercise, Power Plate exercises, and intermittent fasting, along with my standarddietary recommendations. I would strongly encourage you to review my nutrition plan if you haven’t already done so.

Add to that some regular sun exposure, and you’ll be well ahead of most people. Vitamin D, a steroid hormone, also helps to naturally increase testosterone levels. In one study,12 overweight men who were given vitamin D supplements had a significant increase in testosterone levels after one year. As in most instances, given half a chance, your body will actively and automatically strive to maintain optimal health. So as long as you incorporate the foundational basics of a healthy lifestyle, you can stay healthy and strong well into your old age.

Men with COPD, hypogonadism at greater risk for mortality.


Low testosterone levels predicted an increased risk for mortality, particularly in patients with chronic obstructive pulmonary disease, based on evidence from the observational ECLIPSE study.

Richard V. Clark, PhD, MD, director of Discovery Medicine in the Metabolic Therapeutic area of GlaxoSmithKline Research and Development in Durham, N.C., said previous studies have shown that hypogonadism is associated with an increased risk for mortality during a presentation at the Endocrine Society’s 94th Annual Meeting & Expo.

“This survey of looking at a large, well-characterized population of men with a chronic illness — in this case [chronic obstructive pulmonary disease] — was able to show a few correlations with testosterone, but nothing extensive,” Clark said.

Researchers examined the link between total testosterone levels in 1,296 men with chronic obstructive pulmonary disease (COPD) to outcomes and phenotypes from the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study. Patients were studied in 46 centers within 12 countries and categorized in stages II through IV of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. They were followed for 3 years.

Testosterone was measured by turbulent flow liquid chromatography–tandem mass spectrometry (LC/MS/MS) and free testosterone was measured by equilibrium dialysis from samples taken at month 6.

“Testosterone was an independent predictor of mortality,” Clark said.

The median testosterone level was 439 ng/dL, and low testosterone was not found to be correlated with the percentage of predicted forced expiratory volume in one second (FEV1); however, it was strongly correlated with higher BMI (Spearman’s rank correlation coefficient=–0.47) and lower percentage of predicted total lung capacity (Spearman’s rank correlation coefficient=0.21; each P<.001).

According to data, low testosterone was also found to be statistically significant as it related to higher age, shorter 6-minute walk distance and lower emphysema score on a CT scan (P<.05).

When Clark and colleagues performed a univariate analysis, they found that death was more likely to occur in patients with low testosterone levels (OR=0.51; P<.054). Similarly, lower testosterone levels significantly predicted death in patients with stage II COPD (OR=0.24; P<.003).

Multivariate linear regression analysis took into account: age, percentage of predicted FEV1, BMI, smoking status and testosterone level. COPD hospitalization and patient death were predicted by age and percentage FEV1. Yet, testosterone levels were not predictive of COPD hospitalization. Rather, it was only predictive of higher patient death in those with GOLD stage II COPD (OR=0.25; P<.007).

Data showed that median free testosterone levels of 206 pmol/L confirmed the total testosterone findings and did not contribute to the analyses.

Source: Endocrine Today.